Drug intelligence / Profile preview

Guilong Kechuanning

Development stage: Unknown
Lead developer: Reckitt
Modality: Small Molecules
Administration: Oral

Overview

Guilong Kechuanning is an approved Traditional Chinese Medicine (TCM) herbal formulation developed by Guilong Pharmaceutical (Anhui) Co., Ltd. It is indicated for the treatment of respiratory diseases, specifically chronic bronchitis, cough, and asthma. As a multi-herb TCM preparation, it does not have a single defined active ingredient or discrete molecular biological target in the conventional pharmacological sense; instead, it relies on the synergistic effects of its botanical components. The drug is administered orally in capsule form and has been widely used clinically in China, often serving as a positive control comparator in clinical trials evaluating other respiratory treatments.

Brand names: Guilong Kechuanning Capsule
Other names: 桂龙咳喘宁胶囊Guilong Kechuanning Jiaonang

Beyond the preview

Go deeper on Guilong Kechuanning.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guilong Kechuanning.

Explore the full profile